Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Otsuka

Status and phase: Completed; Phase 4

Conditions: Parkinson's Disease; Psychoses

Treatments: Drug: aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00095810

CN138-060

Details and patient eligibility

About

The purpose of this clinical research study is to assess the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primary diagnosis of idiopathic Parkinson's disease.
• Psychosis related to Parkinson's disease.

Exclusion criteria

• Psychosis present prior to diagnosis of Parkinson's disease.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

A

Experimental group

Treatment:

Drug: aripiprazole